Fall Risk and Quality of Life: Influence of Dual Task Performance, Cognition, and Sensorimotor Variables in Individuals With Cancer Treatment Related Peripheral Neuropathy

What this Trial Is About

This research focuses on people who had cancer and developed peripheral neuropathy as a side effect of cancer treatments. It aims to understand how this neuropathy affects thinking, feeling, balance, and movement, and how these factors may increase the risk of falls or affect quality of life. The study also looks at the ability to perform two tasks at once, like walking while texting, which may be challenging for those affected. The study compares two groups: individuals with a history of non-central nervous system cancer who have peripheral neuropathy symptoms caused by their cancer treatments, and age- and gender-matched individuals without neuropathy symptoms. Researchers assess walking patterns, especially backward walking on a computerized mat, along with cognitive, motor, and sensory abilities to explore their impact on fall risk and quality of life. Participants will undergo various assessments including tests for fall risk, quality of life, cognitive functions like working memory and visual attention, grip strength, lower extremity strength, and balance. These evaluations involve single and dual task walking tests and are designed to identify impairments that may predict fall risk or impact quality of life. The study includes healthy volunteers and will continue until June 2026.

Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.